Clinical Trial Update: Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 trial to evaluate the safety and efficacy of oral NXC-736 in adults with moderate to severe alopecia areata; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• NXC-736

Snippet

Sponsor: NEXTGEN Bioscience | Conditions: Alopecia Areata | Phase 2 | Status: RECRUITING